Revance Valuation
| RVNCDelisted Stock | USD 3.65 0.00 0.00% |
At this time, the company appears to be overvalued. Revance holds a recent Real Value of $3.11 per share. The prevailing price of the company is $3.65. Our model determines the value of Revance from analyzing the company fundamentals such as Return On Equity of -20.97, shares outstanding of 104.39 M, and Operating Margin of (0.54) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Revance's price fluctuation is relatively risky at this time. Calculation of the real value of Revance is based on 3 months time horizon. Increasing Revance's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Revance is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Revance Stock. However, Revance's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.65 | Real 3.11 | Hype 3.66 | Naive 3.53 |
The real value of Revance Stock, also known as its intrinsic value, is the underlying worth of Revance Company, which is reflected in its stock price. It is based on Revance's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Revance's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Revance helps investors to forecast how Revance stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Revance more accurately as focusing exclusively on Revance's fundamentals will not take into account other important factors: Revance Total Value Analysis
Revance is at this time estimated to have valuation of 680.39 M with market capitalization of 381.02 M, debt of 478.43 M, and cash on hands of 233.82 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Revance fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
680.39 M | 381.02 M | 478.43 M | 233.82 M |
Revance Investor Information
About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.34. Revance had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Revance's historical financial statements, Revance is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Revance Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Revance has an asset utilization ratio of 48.92 percent. This indicates that the Company is making $0.49 for each dollar of assets. An increasing asset utilization means that Revance is more efficient with each dollar of assets it utilizes for everyday operations.Revance Ownership Allocation
The majority of Revance outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Revance to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Revance. Please pay attention to any change in the institutional holdings of Revance as this could imply that something significant has changed or is about to change at the company. On November 2, 2023, Senator Thomas R Carper of US Senate acquired under $15k worth of Revance's common stock.Revance Profitability Analysis
The company reported the previous year's revenue of 234.04 M. Net Loss for the year was (323.99 M) with profit before overhead, payroll, taxes, and interest of 103.69 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Revance's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Revance and how it compares across the competition.
About Revance Valuation
The delisted stock valuation mechanism determines Revance's current worth on a weekly basis. Our valuation model uses a comparative analysis of Revance. We calculate exposure to Revance's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Revance's related companies.Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee. Revance Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 495 people.
Revance Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 84.6 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Revance Stock
If you are still planning to invest in Revance check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Revance's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |